Vistin Pharma ASA (OSL: VISTN)

Vistin Pharma ASA Statistics

Total Valuation

Vistin Pharma ASA has a market cap or net worth of NOK 1.04 billion. The enterprise value is 1.04 billion.

Market Cap	1.04B
Enterprise Value	1.04B

Important Dates

The next estimated earnings date is Thursday, February 13, 2025.

Earnings Date	Feb 13, 2025
Ex-Dividend Date	Nov 6, 2024

Share Statistics

Vistin Pharma ASA has 44.34 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	44.34M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	37.73%
Owned by Institutions (%)	20.35%
Float	21.17M

Valuation Ratios

The trailing PE ratio is 16.91.

PE Ratio	16.91
Forward PE	n/a
PS Ratio	2.43
PB Ratio	3.34
P/TBV Ratio	3.34
P/FCF Ratio	18.61
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.24, with an EV/FCF ratio of 18.65.

EV / Earnings	16.95
EV / Sales	2.44
EV / EBITDA	10.24
EV / EBIT	12.58
EV / FCF	18.65

Financial Position

The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.03.

Current Ratio	2.13
Quick Ratio	1.06
Debt / Equity	0.03
Debt / EBITDA	0.08
Debt / FCF	0.15
Interest Coverage	11.47

Financial Efficiency

Return on equity (ROE) is 20.06% and return on invested capital (ROIC) is 16.57%.

Return on Equity (ROE)	20.06%
Return on Assets (ROA)	13.34%
Return on Capital (ROIC)	16.57%
Revenue Per Employee	5.69M
Profits Per Employee	818,253
Employee Count	77
Asset Turnover	1.10
Inventory Turnover	1.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.75% in the last 52 weeks. The beta is 0.90, so Vistin Pharma ASA's price volatility has been similar to the market average.

Beta (5Y)	0.90
52-Week Price Change	+5.75%
50-Day Moving Average	24.86
200-Day Moving Average	23.72
Relative Strength Index (RSI)	40.65
Average Volume (20 Days)	6,241

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vistin Pharma ASA had revenue of NOK 426.52 million and earned 61.37 million in profits. Earnings per share was 1.38.

Revenue	426.52M
Gross Profit	277.57M
Operating Income	82.67M
Pretax Income	78.74M
Net Income	61.37M
EBITDA	100.56M
EBIT	82.67M
Earnings Per Share (EPS)	1.38

Balance Sheet

The company has 5.63 million in cash and 8.14 million in debt, giving a net cash position of -2.51 million or -0.06 per share.

Cash & Cash Equivalents	5.63M
Total Debt	8.14M
Net Cash	-2.51M
Net Cash Per Share	-0.06
Equity (Book Value)	310.74M
Book Value Per Share	7.01
Working Capital	76.43M

Cash Flow

In the last 12 months, operating cash flow was 99.86 million and capital expenditures -44.09 million, giving a free cash flow of 55.77 million.

Operating Cash Flow	99.86M
Capital Expenditures	-44.09M
Free Cash Flow	55.77M
FCF Per Share	1.26

Margins

Gross margin is 65.08%, with operating and profit margins of 19.38% and 14.39%.

Gross Margin	65.08%
Operating Margin	19.38%
Pretax Margin	18.46%
Profit Margin	14.39%
EBITDA Margin	23.58%
EBIT Margin	19.38%
FCF Margin	13.08%

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 4.27%.

Dividend Per Share	1.00
Dividend Yield	4.27%
Dividend Growth (YoY)	33.33%
Years of Dividend Growth	1
Payout Ratio	90.30%
Buyback Yield	n/a
Shareholder Yield	4.27%
Earnings Yield	5.91%
FCF Yield	5.37%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Vistin Pharma ASA has an Altman Z-Score of 10.36.

Altman Z-Score	10.36
Piotroski F-Score	n/a